Wnt3a enhances bone morphogenetic protein 9-induced osteogenic differentiation of C3H10T1/2 cells

Chinese Medical Journal

Volumn 126, Issue 24, 2013, Pages 4758-4763

  Zhang, Xiao ^a   Lin, Liang Bo ^a   Xu, Dao Jing ^b   Chen, Rong Fu ^a   Tan, Ji Xiang ^a   Liang, Xi ^a   Hu, Ning ^a   Huang, Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein 9; Mesenchymal stem cell; Osteogenic differentiation; Wnt3a

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; BETA ACTIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 9; CALCIUM; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2; WNT3A PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; COLORIMETRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GROWTH DIFFERENTIATION FACTOR 2; HUMANS; OSTEOCALCIN; OSTEOGENESIS; WNT3A PROTEIN;

EID: 84890325859     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20120741     Document Type: Article

References (44)

1. Pittenger MF, Mzckay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
2. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003; 423: 349-355.
3. Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010; 147: 35-51.
4. Cheng HW, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85-A: 1544-1552.
5. Liu CR, Miao J, Xia Q, Huang HC, Gong C, Yang Q, et al. Tissue-engineered calcium phosphate cement in rabbit femoral condylar bone defects. Chin Med J 2012; 125: 1993-1998.
6. Glass DA 2nd, Karsenty G. In vivo analysis of Wnt signaling in bone. Endocrinology 2007; 148: 2630-2634.
7. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998; 14: 59-88.
8. Nusse R. WNT targets: repression and activation. Trends Genet 1999; 15: 1-3.
9. Moon RT, Brown JD, Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 1997; 13: 157-162.
10. Hülsken J, Behrens J. The Wnt signalling pathway. J Cell Sci 2000; 113 (Pt 20): 3545.
11. Luo J, Chen J, Deng ZL, Luo X, Song WX, Sharff KA, et al. Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest 2007; 87: 97-103.
12. Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005; 8: 739-750.
13. Hill TP, Später D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005; 8: 727-738.
14. Morvan F, Boulukos K, Clément-Lacroix P, Roman Roman S, Suc-Royer I, Vayssière B, et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 2006; 21: 934-945.
15. ten Dijke P, Krause C, de Gorter DJ, Löwik CW, van Bezooijen RL. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. J Bone Joint Surg Am 2008; 90 suppl 18: 31-35.
16. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004; 11: 1312-1320.
17. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, et al. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 2006; 26: 2955-2964.
18. Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, et al. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biolchem 2003; 90: 1149-1165.
19. Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu BA, et al. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004; 279: 32941-32949.
20. Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi RT. BMP signaling is required for Runx2-dependent induction of the osteoblast phenotype. J Bone Miner Res 2006; 21: 637-646.
21. Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 1997; 276: 71-74.
22. Urist MR, Nilsson O, Rasmussen J, Hirota W, Lovell T, Schmalzreid T, et al. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin Orthop Relat Res 1987; (214): 295-304.
23. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-1534.
24. Li HX, Luo X, Liu RX, Yang YJ, Yang GS. Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells. Mol Cell Endocrinol 2008; 291: 116-124.
25. Song JJ, Celeste AJ, Kong FM, Jirtle RL, Rosen V, Thies RS. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 1995; 136: 4293-4297.
26. López-Coviella I, Berse B, Krauss R, Thies RS, Blusztajn JK. Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 2000; 289: 313-316.
27. Jane JA Jr, Dunford BA, Kron A, Pittman DD, Sasaki T, Li JZ, et al. Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 2002; 6: 464-470.
28. Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 2003; 18: 1842-1853.
29. Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, et al. β-Catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem 2005; 94: 403-418.
30. Chen Y, Whetstone HC, Youn A, Nadesan P, Chow EC, Lin AC, et al. β-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 2007; 282: 526-533.
31. DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 2000; 8: 309-334.
32. Ebara S, Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 2002; 27 (16 Suppl 1): S10-S15.
33. Yang Y. Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis. Birth Defects Res C Embryo Today 2003; 69: 305-317.
34. Boland GM, Perkins G, Hall DJ, Tuan RS. Wnt3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004; 93: 1210-1230.
35. Liu Z, Tang Y, Qiu T, Cao X, Clemens TL. A dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. J Biol Chem 2006; 281: 17156-17163.
36. Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 2005; 95: 445-453.
37. Kobayashi T, Kronenberg H. Minireview: transcriptional regulation in development of bone. Endocrinology 2005; 146: 1012-1017.
38. Banerjee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, et al. Runt homology domain Proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 1997; 66: 1-8.
39. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754.
40. Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi RT. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res 2006; 21: 637-646.
41. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem 1999; 274; 31577-31582.
42. Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T. Core-binding factor α1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 2002; 31: 303-312.
43. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, et al. Runx2 is a common Target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000; 20: 8783-8792.
44. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, et al. Canonical Wnt signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005; 280: 33132-33140.